Androgenetic alopecia in men and women
Tóm tắt
Từ khóa
Tài liệu tham khảo
Randall, 1994, Androgens and human hair growth, Clinical Endocrinology, 40, 439, 10.1111/j.1365-2265.1994.tb02483.x
Sinclair, 1999
Hamilton, 1942, Male hormone stimulation is a prerequisite and an incitant in common baldness, Am J Anat, 71, 451, 10.1002/aja.1000710306
Hamilton, 1960, Effect of castration in adolescent and young adult males upon further changes in the proportion of bare and hairy scalp, J Clin Endocrinol Metabol, 20, 1309, 10.1210/jcem-20-10-1309
Simpson, 1997, Hair patterns
Hamilton, 1951, Male pattern hair loss in man, Ann NY Acad Sci, 53, 708, 10.1111/j.1749-6632.1951.tb31971.x
Messenger, 1998, Androgen effects on hair growth, Dermatol Ther, 8, 7
Setty, 1970, Hair patterns of the scalp of white and Negro males, Am J Phys Anthropol, 33, 49, 10.1002/ajpa.1330330108
Bruchner, 1964, Baldness and emphysema, J Louisiana State Med Soc, 116, 329
Cotton, 1972, Factors discriminating men with coronary artery disease from healthy controls, Br H J, 34, 458, 10.1136/hrt.34.5.458
Trevisan, 1993, Baldness and coronary heart disease risk factors, J Clin Epidemiol, 46, 1213, 10.1016/0895-4356(93)90121-G
Cooke, 1979, Male pattern alopecia and coronary artery disease, Br J Dermatol, 101, 455, 10.1111/j.1365-2133.1979.tb00026.x
Kligman, 1988, The comparative histopathology of male pattern baldness and senescent baldness, Clin Dermatol, 6, 108, 10.1016/0738-081X(88)90074-0
Whiting, 1993, Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia, J Am Acad Dermatol, 28, 755, 10.1016/0190-9622(93)70106-4
Oliver, 1989, The dermal papilla and the maintenance of hair growth, 51
Obana, 1996, Dermal papilla cells in macaque alopecia trigger a testosterone-dependant inhibition of follicular cell proliferation, 307
Randall, 1996, The use of dermal papilla cells in studies of normal and abnormal hair follicle biology, Dermatol Clin, 14, 585, 10.1016/S0733-8635(05)70386-7
Van Scott, 1958, Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp, J Invest Dermatol, 31, 281, 10.1038/jid.1958.56
Jahoda, 1998, Cellular and developmental aspects of androgenetic aAlopecia, Exp Dermatol, 7, 235, 10.1111/j.1600-0625.2007.00666.x
Elliot, 1999, Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number, J Invest Dermatol, 113, 873, 10.1046/j.1523-1747.1999.00797.x
Rushton, 1991, Natural progression of male pattern baldness in young men, Clin Exp Dermatol, 16, 188, 10.1111/j.1365-2230.1991.tb00343.x
Hutchinson, 1997, The cross-sectional size and shape of human terminal scalp hair, Br J Dermatol, 136, 159, 10.1111/j.1365-2133.1997.tb14888.x
Kaufman, 1996, Androgen metabolism as it affects hair growth in androgenetic alopecia, Dermatol Clin, 14, 697, 10.1016/S0733-8635(05)70396-X
Griffin, 1989, The resistance syndromes, 1919
Imperato-McGinley, 1974, Steroid 5a reductase deficiency in man, Science, 186, 1213, 10.1126/science.186.4170.1213
Kaufman, 1996, Androgen metabolism as it affects hair growth in androgenetic alopecia, Dermatol Clin, 14, 697, 10.1016/S0733-8635(05)70396-X
Itami, 1991, Characterisation of 5a reductase in cultured dermal papilla cells from beard and occipital scalp hair, J Invest Dermatol, 96, 57, 10.1111/1523-1747.ep12514729
Thipgen, 1993, Tissue distribution and ontogeny of steroid 5a reductase isoenzyme expression, J Clin Invest, 92, 903, 10.1172/JCI116665
Bayne, 1999, Immunohistochemical localisation of types 1 and 2 5a reductase in human scalp, Br J Dermatol, 141, 481, 10.1046/j.1365-2133.1999.03042.x
Sreekumar, 1999, Serum androgens and genetic linkage analysis in early onset androgenetic alopecia, J Invest Dermatol, 113, 277, 10.1046/j.1523-1747.1999.00659.x
Burton, 1979, Male pattern alopecia and masculinity, Br J Dermatol, 100, 567, 10.1111/j.1365-2133.1979.tb05582.x
Sawaya, 1998, Novel agents for the treatment of alopecia, Seminars Cutan Med Surg, 17, 276, 10.1016/S1085-5629(98)80024-2
O’Driscoll, 1994, A prospective study of the A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia, Clin-Endocrinol-Oxf, 41, 231, 10.1111/j.1365-2265.1994.tb02535.x
Thronton, 1998, Androgen-dependant beard dermal papilla cells secrete autocrine growth factor(s) in response to testosterone unlike scalp cells, J Invest Dermatol, 111, 727, 10.1046/j.1523-1747.1998.00396.x
Ludwig, 1977, Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex, Brit J Dermatol, 97, 247, 10.1111/j.1365-2133.1977.tb15179.x
Kuhlwein, 1985, Androgene Alopezie vom weiblichen Typ beim Mann, Z Hautkr, 60, 576
Norstrom, 1979, Synchronous balding of scalp and hair bearing grafts of scalp transplanted to the skin of the arm in male pattern baldness, Acta Derm Venereol, 59, 266, 10.2340/0001555559266268
Orentreich, 1959, Autografts in alopecias and other selected dermatological conditions, Ann NY Acad Sci, 83, 462, 10.1111/j.1749-6632.1960.tb40920.x
Randall, 1992, Cultured dermal papilla cells from androgen-dependent human hair follicles (eg beard) contain more androgen receptors than those from non-balding areas of the scalp, J Endocrinol, 133, 141, 10.1677/joe.0.1330141
Boudou, 1997, Increased scalp and serum 5a reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia, Arch Dermatol, 133, 1129, 10.1001/archderm.133.9.1129
Sawaya, 1997, Different levels of 5a reductase type I and II, aromatase, and androgen receptors in hair follicles of men and women with androgenetic alopecia, J Invest Dermatol, 109, 296, 10.1111/1523-1747.ep12335779
Thornton, 1993, Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells, Clin Endocrinol, 39, 633, 10.1111/j.1365-2265.1993.tb02420.x
Itami, 1990, 5a reductase activity in cultured dermal papilla cells from beard compared with reticular dermal fibroblasts, J Invest Dermatol, 94, 150, 10.1111/1523-1747.ep12874003
Kuster, 1984, The inheritance of common baldness, J Am Acad Dermatol, 11, 921, 10.1016/S0190-9622(84)80498-3
Ellis, 1997, Analysis of candidate genes for androgenetic alopecia, Aust J Dermatol, 38, A317
Carey, 1993, Evidence for a single gene effect causing polycystic ovaries and male pattern baldness, Clin-Endocrinol-Oxf, 38, 653, 10.1111/j.1365-2265.1993.tb02150.x
Carey, 1994, Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17, Hum-Mol-Genet, 3, 1873, 10.1093/hmg/3.10.1873
Franks, 1996, Hypersecretion of androgens by polycystic ovaries, Baillieres Clin Endocrinol Met, 10, 193, 10.1016/S0950-351X(96)80057-7
Ellis, 2001, Polymorphism of the androgen receptor gene is associated with male pattern baldness, J Invest Dermatol, 116, 452, 10.1046/j.1523-1747.2001.01261.x
Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992;26:962–31.
Cash, 1990, Losing hair, losing points? The effects of male pattern baldness on social impression formation, J Appl Soc Psychol, 130, 209
Cash, 1988, Poor body image, Med Asp Hum Sexual, 22, 67
Cash, 1999, The psychosocial consequences of androgenetic alopecia, Br J Dermatol, 141, 398, 10.1046/j.1365-2133.1999.03030.x
Cash, 1993, Psychological effects of androgenetic alopecia on women, J Am Acad Dermatol, 29, 568, 10.1016/0190-9622(93)70223-G
Kalick, 1994, Psychological characteristics of alopecia patients, Arch Dermatol, 130, 907, 10.1001/archderm.130.7.907
Eckert, 1976, Diffuse hair loss in women. The psychopathology of those who complain, Acta Psychiatr Scand, 53, 321, 10.1111/j.1600-0447.1976.tb00079.x
Chong, 1999, The hair pull test and the hair pluck for analysis of hair abnormalities, Modern Medicine, 42, 105
O’Driscoll, 1994, A prospective study of the prevalence of clear cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenetic alopecia, Clin Endocrinol Oxf, 41, 231, 10.1111/j.1365-2265.1994.tb02535.x
Venning, 1988, Patterned androgenetic alopecia in women, J Am Acad Dermatol, 18, 1073, 10.1016/S0190-9622(88)70108-5
Orentreich, 1995, Androgenetic alopecia and its treatment, a historical view, 1
Olsen, 1990, Natural history of androgenetic alopecia, Clin Exp Dermatol, 15, 34, 10.1111/j.1365-2230.1990.tb02015.x
Hecht A. Hair grower and hair-loss prevention drugs. FDA Consumer 1985;(April 19):.
Peluso AM, Misciali C, Vincenzi C, et al. Diffuse hypertrichosis during treatment with 5% minoxidil. Br J Dermatol 1997;136:118–12.
Devine, 1977, Minoxidil for severe hypertension after failure of other hypotensive drugs, Br Med J, ii, 667, 10.1136/bmj.2.6088.667
Ohtsuyama, 1996, Minoxidil sulfate effect on internal calcium of cell in the epidermis and epidermal appendages, 481
Savin, 1987, Use of topical minoxidil in the treatment of male pattern baldness, J Am Acad Dermatol, 16, 696, 10.1016/S0190-9622(87)70090-5
Olsen, 1987, Long term follow up of men with androgenetic alopecia treated with topical minoxidil, J Am Acad Dermatol, 16, 688, 10.1016/S0190-9622(87)70089-9
Olsen, 1987, Topical Minoxidil in male pattern baldness, J Am Acad Dermatol, 17, 97, 10.1016/S0190-9622(87)70179-0
Bazzano GS, Terezakia N, Galen W. Topical tretinoin for hair growth promotion. J Am Acad Dermatol 1986;15: 880–3 and 890–3.
Dey, 2000, Short and curly, MJA, 172, 47
Shapiro, 1998, Hair regrowth, Dermatol Ther, 16, 341
Rietschel, 1987, Safety and efficacy of topical minoxidil in the management of androgenetic alopecia, J Am Acad Dermatol, 16, 677, 10.1016/S0190-9622(87)70087-5
Drake, 1999, The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia, J Am Acad Dermatol, 41, 550
Roberts, 1999, Clinical dose ranging studies with finasteride, a type 2 5 a reductase inhibitor, in men with male pattern hair loss, J Am Acad Dermatol, 41, 555
Kaufman, 1998, Finasteride in the treatment of men with androgenetic alopecia, J Am Acad Dermatol, 39, 578, 10.1016/S0190-9622(98)70007-6
Leyden, 1999, Finasteride in the treatment of men with frontal male pattern hair loss, J Am Acad Dermatol, 40, 930, 10.1016/S0190-9622(99)70081-2
Rushton, 1996, Topical 0.05% finasteride significantly reduced serum DHT concentrations, but had no effect in preventing the expression of genetic hair loss in men, 359
DeVillez, 1994, Androgenetic alopecia in the female. Treatment with 2% minoxidil solution, Arch Dermatol, 130, 303, 10.1001/archderm.130.3.303
Sinclair, 1998, Common baldness in men and women, Modern Medicine, 41, 54
Olsen, 1994, Androgenetic alopecia, 274
Young, 1998, Continuing medical education, Australas J Dermatol, 39, 24, 10.1111/j.1440-0960.1998.tb01236.x
Young R, Sinclair RD. Continuing medical education: Hirsutes part 2. Australas J Dermatol 1998;39:151–17.
Burke, 1985, Oral spironolactone for female patients with acne, hirsutism or androgenetic alopecia, Br J Dermatol, 112, 124, 10.1111/j.1365-2133.1985.tb02305.x
Shaw, 1991, Spironolactone in dermatological therapy, J Am Acad Dermatol, 24, 236, 10.1016/0190-9622(91)70034-Y
Neuman, 1983, Pharmacological basis for clinical use of antiandrogens, J Steroid Biochem, 19, 391, 10.1016/S0022-4731(83)80052-1
Pereboom-Wynia, 1989, The effects of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females, Acta Dermatol Venereol, 69, 395
Barth, 1991, Cyproterone acetate for severe hirsutism, J Clin Endocrin, 35, 5, 10.1111/j.1365-2265.1991.tb03489.x
Dawber, 1982, Oral antiandrogen treatment of common baldness in women, Br J Dermatol, 107, 20
Van Wayjen, 1995, Experience in the long term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations, Exp Clin Endocrinol Diabetes, 103, 241, 10.1055/s-0029-1211357
Barker, 1987, The epidemiological evidence relating to spironolactone and malignant disease in man, J Drug Develop, 1, 22
Grigoriou, 1996, Comparison of flutamide and cyproterone acetate in the treatment of hirsutism, Gynecol Endocrinol, 10, 119, 10.3109/09513599609097901
Cusan, 1995, Comparison of flutamide and spironolactone in the treatment of hirsutism, Fertil Steril, 63, 680
Roberts J, Hordinsky M, Olsen E, et al. The effects of finasteride on post-menopausal women with androgenetic alopecia. Hair Workshop. Brussels, May 2–5, 1998 (abst.).
Unger, 1994, Surgical approach to hair loss, 353
Auerback, 1980, Dangers of synthetic fiber implantation for male pattern baldness, Cutis, 26, 416
Lepaw, 1979, Complications of implantation of synthetic fibres into scalps for ’hair’ replacement, J Dermatol Surg Oncol, 5, 201, 10.1111/j.1524-4725.1979.tb00643.x
Chen, 1996, The 5a Reductase System and its inhibitors. Recent development and its perspective in treating androgen dependant skin disorders, Dermatology, 193, 177, 10.1159/000246242
Sinclair, 1997, Androgen metabolism and human hair growth, Chemistry in Australia, 64, 12
Li, 1995, The feasibility of targeted selective gene therapy of the hair follicle, Nat-Med, 1, 705, 10.1038/nm0795-705